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Abstract
Sierra Elizabeth Melli
GENE EXPRESSION ANALYSIS REVEALED THE ACTIVATION OF
IMMUNE RESPONSES DURING THE POSTNATAL DEVELOPMENT OF THE
CEREBELLUM IN A MOUSE MODEL OF NIEMANN-PICK TYPE C
2021-2022
Ileana Soto Reyes, Ph.D.
Master of Science in Bioinformatics
Niemann-Pick Type C (NPC) is a recessive neurodegenerative lysosomal
storage disorder that is caused by autosomal recessive mutations. The mutations result
in the inactivation of NPC1 and NPC2 proteins. Inactivation of the NPC1 protein
results in the accumulation of cholesterol within the endosomal and lysosomal
compartments of cells including Cerebellar Purkinje cells. This accumulation of
cholesterol leads to symptoms of dementia, neurodegeneration and potential of early
childhood death in cases of early onset. In this study, we analyze the gene expression
levels using the RNAseq technique in order to determine whether there is a
significant difference between the expression of genes found in the cerebellum of
Niemann-pick type C and wild type mouse models during development. Sholl
Analysis of the dendritic tree from Purkinje cells in an NPC1 mouse model showed
an increase in size and branching at P14 when compared to the size and branching of
the Wild-Type (WT) mouse. RNA gene expression analysis indicated significantly
upregulated and downregulated genes in the NPC mouse models when compared to
WT mouse models. There were no significant gene ontology results from the
downregulated genes, but among the upregulated genes, significant changes in
biological processes involving inflammatory responses were found.
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Chapter 1
Introduction
Niemann-Pick Diseases
The diseases known as Niemann-Pick (NP) are part of a subset of lysosomal
storage disorders known as sphingolipidoses, which are caused by autosomal
recessive mutations that are autosomal recessive and characterized by accumulation
of lipids in lysosomes. These disorders were first described by Albert Niemann and
Ludwick Pick in the early 20th century (Newton et al., 2018, Torres et al., 2017).
Though they were initially thought to be a single entity, it was discovered that the
different diseases can be caused by different etiological causes. Niemann-Pick type A
(NPA) and type B (NPB) are caused by deficits in the acid sphingomyelinase
(ASMase) activity. ASMase is active in lysosomes as well as exhibiting a secretory
form that generates ceramide from sphingomyelin (SM) hydrolysis on the plasma
membrane in response to stress (Torres et al. 2017, Falcone et al. 2004; Charruyer et
al. 2005). These ASMase deficiencies result in the accumulation of SM. Patients with
NPA present with developmental delay and progressive neurodegeneration and
typically die between 2 and 3 years old. Patients who have NPA show a significant
reduction in ASMase activity, presenting with <5% of its physiological activity. NPA
and NPB are both considered to be pan-ethnic, but the diseases do appear more
frequently in certain ethnicities. NPA appears more frequently in individuals who are
of Ashkenazi Jewish descent and it has a carrier frequency of 1:80 with 1/140,000
individuals getting the disease (Torres et al., 2017). NPB has a highly variable
phenotype. Patients who are diagnosed in childhood typically present with
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hepatosplenomegaly. Unlike NPA patients, most NPB patients do not show
symptoms related to neurological deficits, which may be why they typically live into
adulthood. NPB patients do show major complications with pulmonary deterioration
as well as liver damage with fibrosis and cirrhosis. NPB patients, unlike NPA
patients, show an increase in ASMase activity. NPB has a lower carrier frequency,
1:106, in Chilean populations with 90% occurrence in patients and a predicted disease
incidence of 1/45,000. Both NPA and NPB patients accumulate SM primarily in
endolysosomes. Their tissues also show an increase in cholesterol secondary to the
SM accumulation. This effect is due to the SM binding to the cholesterol with high
affinity causing a decrease in efflux of cholesterol out of lysosomes and an increase in
lysosomal cholesterol content as a result (Torres et al., 2017).
Niemann-Pick Type C Disease
Type C of Niemann-Pick disease (NPC) is a recessive neurodegenerative
genetic lysosomal storage disorder which is caused by mutations in the NPC1 and
NPC2 proteins. The NPC1 and NPC2 proteins play an important role in the transport
of cholesterol out of lysosomes and endosomes (Patterson et al., 2013). Ninety-five
percent of Niemann-Pick type C cases are caused by mutations of the NPC1 gene,
located on chromosome 18q11. The NPC2 gene is located on chromosome 14q24 and
mutations of this gene account for the remaining 5% of NPC cases. NPC1 is a
transmembrane protein located in late endosomes and lysosomes while NPC2 is a
small protein located in the lysosomal lumen. These proteins work together to release
cholesterol from within lysosomes. It is currently believed that the NPC2 protein
binds the cholesterol in the lysosomes and transfers it to the NPC1 protein (Torres et
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al., 2017). The NPC1 protein then transports the bound cholesterol to the
endosomal/lysosomal membrane through the glycocalyx for release from the
lysosomes. When there is an NPC1 deficiency there is an accumulation of
unesterified cholesterol in endolysosomes which also causes an increase in SM
(Torres et al., 2017). These mutations in the NPC1 and NPC2 genes cause functional
inactivation of the NPC1 and NPC2 proteins as well as lack of production of the
NPC1 protein (Woś et al., 2016). The mutations cause an accumulation of cholesterol
inside endosomal and lysosomal compartments which leads to progressive
neurodegeneration, dementia, and early death usually during childhood (Patterson et
al., 2013). NPC is a deadly disease that has a disease incidence of 1/120,000
(Patterson et al., 2013, Torres et al., 2017).
Niemann-Pick Type C Age of Onset
In most NPC patients, the age of onset occurs during early infancy (less than 2
years) to adolescent or adult onset (15 years or older) (Piroth et al., 2017). In a study
by Patterson et al, the average age of diagnosis for NPC was 10 years with the
average age of death being 16.2 years. Half of the patients were diagnosed before the
age of 6.9 years and half of those patients died before 12.5 years old. The prognosis
for patients correlates directly with age of onset of the neurological symptoms
(Patterson et al., 2013). Early onset forms of NPC progress faster than delayed or late
onset phenotypes (Mengel et al., 2013). The early onset phenotype is rapidly
progressive and associated with hepatic dysfunction as well as infancy psychomotor
delay. The delayed-onset phenotype shows mild intellectual impairment during early
childhood and is a slowly progressive form. The late onset phenotype is also slowly
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progressive and shows intellectual impairment that presents during adolescence or
adulthood (Garver et al., 2007). Adult onset of NPC1 is rare and these patients
typically present with a heterogeneous spectrum of symptoms (Piroth et al., 2017)
(Figure 1).
Symptoms of Niemann-Pick Type C
Symptoms of NPC can vary depending on the age of onset of the disease.
Early onset or infantile manifestations show neurological symptoms such as
clumsiness, gait problems, motor milestone delays, speech delay, and vertical gaze
palsy (Figure 1). Juvenile and adult onset symptoms include ataxia, cognitive decline,
psychiatric disorders, and dystonia (Patterson et al., 2013, Mengel et al., 2013)
(Figure 1).
Adult onset clinical symptoms also include vertical supranuclear gaze palsy
(VSGP), cerebellar symptoms, and sometimes epilepsy. This heterogeneous spectrum
of symptoms causes NPC to be overlooked in adults. It can often take several years to
diagnose NPC due to a mild presentation of VSGP (Piroth et al., 2017). In most of the
NPC cases, the severity of the disease is determined by systemic signs and
neurological deterioration. Cholestatic jaundice in the neonatal period and
hepatosplenomegaly in childhood typically precede neurological symptoms/defects
(Torres et al., 2017). As it progresses, the disease causes prominent neuronal death,
particularly affecting Purkinje cells (PC) of the cerebellum (Vanier, 2010). Vanier’s
study showed that patients who had shown neurological signs earlier in life tend to
die because of the severity of their symptoms while those who had neurological signs
start later in life have milder symptoms and live (Figure 2).
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Figure 1
Niemann-Pick
Pick Type C Neurological Symptoms Onset and Involvement

Note. Representation of the age of onset and type of neurological symptoms first seen
in Niemann-Pick
Pick Type C. Image taken from Vanier, 2010.
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Figure 2
Patient Lifespan vs. Age of Onset of Niemann Pick
Pick-Type C

Note. Study done on 97 patients from French hospitals with each bar depicting one
patient. The green indicates the time where the patient was not showing any
neurological symptoms regardless of the patient having a preexisting disease or not.
The line becomes redd at the time when the neurological signs begin and ends when
the patient dies from the disease. The line turns blue when the patient’s neurological
signs start but the patient did not die from the disease. Image taken from Vanier,
2010.
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Linkage to the Brain’s Cerebellum and the Development of Purkinje Cells
The cerebellum is a large part of the brain that makes up nearly ten percent of the
human brain's total weight. The cerebellum contains more neurons than the remaining
parts of the brain due to its densely packed granule cells found within the cerebellar
cortex (Glickstein, 2007). Within the cerebellum is the PC layer. This layer is
composed of clusters of PCs. During embryonic development these PC clusters are
sometimes located beneath other clusters. The development of the PCs dendritic tree
occurs throughout postnatal development. A study by Sugihara and Fujita looked at
the postnatal development of these neurons in mice and discovered the following
results about the PC layer. PC clusters begin to rearrange becoming thinner and are
located less frequently beneath other PC clusters at postnatal day 0 (P0) and day 1
(P1). The clusters that are located beneath others move upwards and laterally
allowing them to face the PC layer. At P1, the PCs begin to flatten out and align more
within a single plane within the PC layer. At P6, the PC layer becomes a single cell
thick and the foliation of all major lobules is now recognizable. The spaces within
this layer that do not contain PCs are granule cell ridges that divide the layer into
divisions creating a stripe of PCs. The gaps between PC clusters in embryonic stages
of development become the GC ridges in postnatal development as of P6 (Sugihara &
Fujita 2013). NPC proteins are present in all cell types, but the loss of NPC function
is seen more dramatically in the cerebellar PC. These PCs show extreme sensitivity to
the loss of this NPC protein’s function. The loss of these PCs is the most welldocumented and striking histological change in mouse models of NPC1 (Ko, 2005).
Typically, the progressive loss of PCs causes patients to develop severe cerebellar
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ataxia due to the PCs being the only cells that project out of the cerebellar cortex
(Marschalek et al., 2014).
Disruption of cholesterol transport and storage is associated with cellular
dysfunctions such as distribution of cellular organelles, deregulation of intracellular
localization of proteins or expression changes in several genes involved in signaling
pathway and altered properties of the plasma membrane and endoplasmic reticulum
(ER) (Vilaça et al., 2014). Cellular abnormalities associated with the NPC phenotype
include abnormalities in functioning and morphology of the ER and the Golgi
apparatus as well as deregulation of the entire cell vesicular traffic machinery (Coxey
et al., 1993, Nakasone et al., 2014, Sobo et al., 2007).
Previous Findings by Our Laboratory
In our laboratory, it was previously investigated how deficiency of NPC1 affects
the development, activity, and interaction of microglia with PCs and climbing fibers.
We studied microglia in Npc1nmf164 mice, which are NPC mice with the N-ethyl-Nnitrosourea point mutation, at different developmental and degenerative stages of the
NPC disease. By studying the disease in stages, we were able to determine that the
activation of microglia occurs early in the cerebellar molecular layer where the PC
dendrites reside. In stages where significant loss of PCs was found, there were
significant changes in microglia in the Npc1nmf164mouse cerebellum. In the mutant
mice, the density of microglia, when compared to 4-week mice, was significantly
higher at 8 and 12 weeks. However, there were no significant differences found in the
Wild Type (WT) mice microglia at all ages. Even during postnatal and early stages of
the disease when no PC degeneration has occurred, the activation of microglia in the
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molecular layer was evident in the anterior lobes of the Npc1nmf164 cerebellum
cerebel
(Figure
3). This suggested to us that PC death is preceded by microglia activation (Figure 4).

Figure 3
Early Changes in Microglia in NPC1 Mouse M
Models

Note. The proliferation and migration of the microglia precursor cells and
differentiating microglia is affected by the deficiency of NPC1 in the postnatal
cerebellum of mouse models.

9

Figure 4
Early Phagocytic
ytic and M
Microglial Interactions with PC Dendrites in NPC1 Mice
Compared to WT Mice
ice

Note. Using immunostaining techniques to stain phagosomes (red), microglia (cyan)
and Purkinje cells (green), we were able to analyze the changes in the morphology of
the microglia over time as well as tthe number of CD-68
68 phagosomes and IBA1+
microglial cells and the volume of the phagosomes in the WT and NPC mouse
models.

While studying microglia activation, we also found that microglia of
Npc1nmf164 mice showed morphological changes such as increased cell body size as
well as thicker and retracted processes
processes. This characterized microglia activation. There
were no significant differences between WT mice, so the 4 week WT was
w used to
compare to 8 and 12 week Npc1nmf164mice. IBA1+ cells total cell volume was
significantly increased in 4-week-oldNpc1nmf164mice when compared to the WT mice.
In both 4 week and 12
12-week-oldNpc1nmf164 mice the mean volume of the microglial
processes was significantly increased when compared to the WT mic
mice.
e. We found that
the number of CD-68
68 phagosomes in the Npc1nmf164 mice at 4 and 12 weeks was
w
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significantly reduced compared to the WT mice. Though there were less phagosomes
in the 4 and 12 weeks Npc1nmf164 mice, the average volume of the phagosomes was
significantly increased compared to the WT (Figure 4), suggesting high phagocytic
activity and the accumulation of unresolved phagosomes (Kavetsky et al., 2019).
With these data suggesting that there is a correlation between the degeneration of
dendrites in Npc1nmf164 mice and the phagocytic activity of activated microglia, we
hypothesized that PC degeneration would be accelerated with an increase in microglia
activity. We used a western diet (WD) to increase the microglia activity in Npc1nmf164
mice since it is known to induce microglial activation in Alzheimer’s disease mouse
models (Graham et. al 2016). A control group of littermate mice were fed a regular
diet (RD), while WT and NPC mice were fed a WD. Analysis after 5 weeks of the
WD showed no significant differences between the density of microglia of the WT
mice eating WD and WT mice eating RD. When compared to both WT-RD and
Npc1nmf164-RD mice, 8-week-old Npc1nmf164 -WD mice showed a significant increase
in average activated microglia density per lobe in the ML. We also discovered that
there was a significantly greater increase in average microglia density in Npc1nmf164 WD within the ML of the first two lobules (I and II) of the anterior cerebellum. There
was, however, no significant difference in the average linear density of PCs per lobe
between Npc1nmf164 -RD and Npc1nmf164 -WD. Image analysis of the ML of the
Npc1nmf164 -WD mice showed evident absence of calbindin immunostained dendrites
when compared to the Npc1nmf164 -RD mice. PC somata and an abundance of
activated microglia were observed in areas of complete absence of dendrites.
However, quantitative analysis showed no significant difference between WT-RD and
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Npc1nmf164 -RD
RD mice when comparing the CALB+ dendritic aarea
rea in the ML of
cerebellar lobules I and II.
After discovering changes in the microglia of Npc1nmf164 mice occurring early on
in development, we considered that these changes might be due to an innate immune
response causing an upregulation in genes wit
within the P30 Npc1nmf164 mouse
cerebellum. We tested this hypothesis using 96 well plates containing primers for 92
genes that are associated with the Npc1nmf164 mouse cerebellum while P90 Npc1nmf164
mouse RNA was used as a control. After qRT
qRT-PCR analysis, wee discovered that there
were genes upregulated in the P90 Npc1nmf164 mouse cerebellum when compared to
the WT mice (Figure 5). Although there was upregulation at P90, there was no
significant difference in the gene expression in Npc1nmf164 P30 mice (Figure 5). These
findings suggest that the early changes in microglia are not the result of an innate
immune response.

Figure 5
Difference in Innate Immune Response Genes in NPC1 Mice
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Note. Changes in expression of genes that are associated with an innate immune
response between Npc1nmf164 mice at 30 days (P30, red, n=3) and 90 days (P90, blue,
n=3) of age when compared to that of the WT (n=4). *P<0.05, **P<0.01,
***P<0.001. Scale bar: 30 µm.

After determining the effects on microglia and the increase in abundance of
activated microglia in the Npc1nmf164 mouse ML, we hypothesized that the increase in
activated microglia would cause greater degeneration of PC dendrites in Npc1nmf164
mice when compared to that of WT mice. In this study, we analyzed the length and
branching of PC dendrites of both Npc1nmf164 mice and WT mice atP14 and P30 to
investigate the degeneration of PC dendrites throughout development and how this
degeneration differs between genotypes. We also performed RNAseq analysis using
RNA samples from WT and Npc1nmf164 mice at P14, to determine which genes are
differentially expressed. We then used gene ontology to determine which biological
processes could be potentially involved in the developmental changes in PC dendrites
that precede neurodegeneration in Niemann-Pick type C.
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Chapter 2
Materials and Methods

Animals
All experiments that involved mice were performed in accordance with
procedures and policies in Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health and were conducted by Animal Care and Use
Committees at Rowan University School of Osteopathic Medicine. The mutant mouse
strain that is NPC1 deficient, C57BL/6J-Npc1nmf164/J (referred to in this study as NPC
mice, Jax stock number 004817), was supplied by Dr. Robert Burgess at The Jackson
Laboratory. To generate WT and Npc1nmf164 homozygous mutant mice, Npc1nmf164
heterozygous mice were housed and bred in a 12/12-h light/dark cycle. Both male and
female mice were used in this study at a 2:2 ratio when 4 mice were used per
genotype and age.
Golgi-Cox Staining Technique
The FD Rapid GolgiStain™ Kit was used throughout this procedure as a way of
executing Golgi-Cox impregnation and dendrite visualization. Using the
impregnation technique, we can visualize subtle morphological changes in neuronal
dendrites and their dendritic spines in postmortem brains. This impregnation method
is one of the most effective techniques for studying normal and abnormal neurons.
The FD Rapid GolgiStain™ Kit has been proven to be extremely reliable and provide
the best results when used to demonstrate morphological changes in neurons and glia.

14

The kit has been used and tested on a variety of different species brains including that
of humans postmortem.
Tissue Collection and Preparation
Tissue Collection
Mouse specimens were euthanized using carbon dioxide following all humane
animal treatment protocols approved by the IACUC committee at Rowan University.
Once the head was dissected away from the remaining part of the body, the skin was
stripped off the skull. The skull was then gently opened using dissecting scissors and
full brain removal was performed with blunt forceps.
Tissue Impregnation
Each brain was immediately immersed in an impregnation solution made with
equal parts of Solutions A and B from the FD Rapid GolgiStain™ Kit, at room
temperature, and placed in a light free environment. The immersion solution mixture
was replaced the day after immersion and the brain tissue continued to be incubated
in the dark, at room temperature, for 2 weeks. The brain tissue was then washed and
immersed into Solution C, then incubated for 72 hours at room temperature.
Tissue Sectioning
Following tissue preparation and impregnation treatment, the intact mouse
brain tissue was cut into two halves labeled as the left and the right brain tissue. Each
half of the brain was then placed into a cube containing optimal compound
temperature (OCT) media and frozen at -80℃ for at least 24 hours. Only after the
OCT media was fully frozen, 160 µm sections were sliced on a cryostat set to -20°C.
Once a tissue section was cut, it was collected using cold forceps and placed into a
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well containing Solution C from the FD Rapid GolgiStain™ Kit. While in Solution C,
each individual tissue section was isolated away from other tissue and the cerebellum
was extracted away from the remaining brain tissue of each section using small soft
bristle paint brushes and placed into another well containing Solution C.
Staining Procedure
Tissue sections were rinsed in distilled water prior to being immersed in a
solution containing one part Solution D, one part Solution E and two parts distilled
water before being rinsed twice in distilled water. The tissue sections were then
mounted onto slides using Solution C and allowed to dry for 2 days at room
temperature, in the dark. After the tissue sections were dried and became adherent to
the slide, the mounted tissues were transported to a chemical hood where they were
dehydrated in 75%, 85% and 100% (5 minutes for each dehydration step) ethanol
prior to being immersed in Histo-Clear for 8 minutes. Slides were sealed using
Permount and allowed to dry overnight prior to analysis. This processing results in a
stained Purkinje cell that is black in color (Figure 8a).
Golgi-Cox Microscopy Image Analysis
Purkinje cell dendrite length was measured using the ImageJ Simple Neurite
Tracer Plugin. Dendrite length was measured for both WT and NPC mice at P14 and
P30. The total length and the number of intersections (branching) of the dendrites
were calculated using Sholl Analysis of the branch tracings (Figure 6 a-d, Figure 7)
within the ImageJ software.
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Figure 6
Dendritic Tree Staining and Measuring Techniques

Note. ImageJ measurement analysis of A) 14d WT B) 14d NPC C) 30d WT D) 30d NPC
measuring the length of the dendritic tree as well as the number of intersections
(representing the amount of branching within the tree).
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Figure 7
Sholl Analysis of a Purkinje Cell

Note. Example of how Sholl Analysis is done. The radius of each circle is measured and
every intersection of the dendrites into these individual circles is recorded to determine
branching and size of the PC dendrites.

Tissue Collection and RNA Purification for RNA Analysis
Cerebellar tissue from WT and Npc1nmf164 mice was collected from the mouse
specimen following CO2 euthanasia. The mouse specimens were perfused with PBS in
order to drain the blood from the mouse. Phosphate
Phosphate-buffered saline (PBS)
PBS) perfusion was
followed by perfusion of paraformaldehyde to fix the tissues prior to extraction. After
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stripping the skin from the mouse skull, the skull was gently opened using dissecting
scissors and the brain was removed from within the skull using blunt forceps. The
cerebellum was separated from the rest of the brain and was used for the extraction of
RNA. The TRIzol Plus RNA Purification Kit was used for RNA isolation and
purification. The total RNA samples obtained in this manner were shipped on dry ice to
the biotech biotechnology company Genewiz for RNA sequencing.
RNA Samples and Sequencing
Eight RNA samples, 4 WT and 4 NPC1 were provided to Genewiz for them to
process with Illumina sequencing. The sequencing was done as 150 base pair (bp) pairedend sequencing. This approach facilitates sequencing of both the 5' and 3' ends of each
RNA sample for our lab to see each sample sequenced from the 5’ end as well as the 3’
end as two individual files (these distinctions are labeled with the sample ID “R1” or
“R2”, as can be observed as in Table 1).
Prior to sequencing, the RNA samples were evaluated for several attributes: RNA
integrity, RNA concentration and quality of the samples. Genewiz then selected
polyadenylated mRNAs and added sequencing adapters to the RNA prior to Illumina
sequencing. These adapters are added to the 5’ and 3’ ends of the RNA fragments acting
as recognition fragments for the sequencing equipment. The data was then further
analyzed using FastQC to determine the quality of the reads, Bowtie2 to align the reads
of each sample, and Cufflinks to calculate the gene expression that occurs within the WT
and NPC mice. Cufflinks were further used to determine if there is a difference in
expression between the two mouse genotypes that would explain behavioral or molecular
changes within the mice.
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Table 1
Breakdown of Study Samples
Sample ID

Genotype

Mouse
ID

Litter

Age
(days)

Run

15d1WT_R1_001

WT

15d1

WT
Breeder

15

Run 1

15d1WT_R2_001

WT

15d1

WT
Breeder

15

Run 2

15d2NPC_R1_001

NPC

15d2

M23-2

15

Run 1

15d2NPC_R2_001

NPC

15d2

M23-2

15

Run 2

15d2WT_R1_001

WT

15d2

WT
Breeder

15

Run 1

15d2WT_R2_001

WT

15d2

WT
Breeder

15

Run 2

15d7NPC_R1_001

NPC

15d7

M23-2

15

Run 1

15d7NPC_R2_001

NPC

15d7

M23-2

15

Run 2

P8-3-15d1WT_R1_001

WT

15d1

15

Run 1

P8-3-15d1WT_R2_001

WT

15d1

15

Run 2

P8-3-15d4NPC_R1_001

NPC

15d4

15

Run 1

P8-3-15d4NPC_R2_001

NPC

15d4

15

Run 2

P8-3-15d5WT_R1_001

WT

15d5

15

Run 1

P8-3-15d5WT_R2_001

WT

15d5

15

Run 2

P8-3-15d6NPC_R1_001

NPC

15d6

15

Run 1

P8-3
P8-3
P8-3
P8-3
P8-3
P8-3
P8-3

P8-3-15d6NPC
15d6
15
Run 2
NPC_R2_001
P8-3
Note. We had 8 samples of RNA that were sent to Genewiz Biotechnology Company of
which 16 data sets were returned from the paired-end analysis (Table 1). Each sample
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was sequenced from the 5” end and the 3” end of the sequence resulting in two data sets
for each sample. The litter ID of the mouse specimen is made up of the mating ID (ex:
P8) and what number litter it was since the mating pair was set up (ex: P8-3 means that
that mouse came from mating P8 and it was the third litter from that mating pair). The
mouse ID is created from the age of the mouse and the number of the mouse from that
litter (ex: 15d1 means that the mouse was 15 days old and it was the first mouse from that
litter).

RNA Quality Assessment using FASTQC
Prior to gene expression analysis, the raw data of all 8 samples were analyzed for
their quality (purity and integrity). Each sample had a forward and reverse data set sent
back from Genewiz resulting in 16 sets to analyze with FASTQC. FASTQC provides an
overview of quality metrics for raw data from next generation sequencing. The FASTQC
software was run on a Linux terminal in a non-interactive mode which generated an
HTML report per sample. The results of FASTQC analysis supplies researchers with 11
modules regarding quality assessment. These 11 modules are as follows: basic statistics,
per base sequence quality, per tile sequence quality, per sequence quality scores, per base
sequence content, per sequence GC content, per base N content, sequence length
distribution, sequence duplication levels, overrepresented sequences, and adapter content.
The basic statistics of each RNA sample acts as a quick overview of the sample giving
details about the sample/file name, file type, encoding, total sequences, sequences
flagged as poor quality, sequence length of the sample, and GC percentage. The
sequenced samples all had Sanger/Illumina 1.9 encoding and a file type of conventional
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base calls (Table 2). Once each sample was reviewed, we determined whether sequence
length trimming was necessary and proceeded with the sequence alignments.
RNA Sequencing Paired- End Alignment
When the quality of the reads was accepted as an overall good or great quality, the
sequences were aligned to the GRCm38 mouse reference genome using Bowtie2
software. The fastq files of each sample were used to align the sample sequences with
that of the reference genome. The Bowtie2 software was also run as paired ends with
each sample being paired together with their "R1" and "R2" data sets (seen in Table 1).
After each sample was aligned, the program provided alignment results. These results
include the total number of reads, how many of those reads were paired, how many were
paired concordantly 0, 1, or greater than 1 time. The program then breaks down the pairs
that aligned concordantly 0 times into how many of those pairs aligned discordantly.
Further breakdown shows pairs that aligned 0 times both concordantly and discordantly
into mates that make up pairs and how the mates aligned (0, 1, or greater than 1 time).
Each alignment result also comes with an overall alignment rate in percentage. Post
sequence alignments, the sixteen sets of results were made into separate SAM files
(.sam). Prior to using the paired-end reads for gene expression analysis, the SAM files
were converted to BAM (.bam) files and sorted to match the reference sequence
chromosome arrangement in order to use gene expression software.
Utilization of Cufflinks for Gene Expression of NPC and WT Mouse Models
To determine if there is a difference between the gene expression of wild type
mice and those who have Niemann-Pick Type C, we had to evaluate the gene expression
within each mouse sample. To do this, we used Cufflinks software for transcription

22

analysis. The Cufflinks software package includes several features including Cufflinks,
Cuffcompare, Cuffmerge, and Cuffdiff. Cufflinks is used to assemble the transcripts.
Cuffcompare is used to compare transcript assemblies to annotations. Cuffmerge is used
to merge two or more transcript assemblies. Cuffdiff is used to find differentially
expressed genes and transcripts and detect differential splicing and promoter use. We
utilized the Cuffdiff program within the Cufflinks software package to determine the
gene expression in each RNA sample sequence.
The results from the Cuffdiff expression analysis provided us with the names of
all the genes within the sample sequences as well as the fragments per kilobase million
(FPKM) values of each gene for each sample. The FPKM values give insight into the
gene expression values of every gene in each of the RNA-seq samples. We compared the
FPKM values of the NPC RNA-seq samples to that of the Wild Type RNA-seq samples.
For both the NPC and the wild type samples, the average FPKM value was calculated.
Further calculations for analysis included the log2 value, the p-value, the fold change and
fold difference as well as the overall average FPKM value for all RNA-seq samples (NPC
and WT together).
Of the 28,473 genes reported in the Cuffdiff results, we filtered out a general list
of the genes that had a significant difference between the FPKM of the NPC and WT
mice (all data with p-value≤ 0.05 were considered statistically significant). When
compiling this gene list, false discovery rates were not taken into account. From this
general list, we created two more specific lists, one list of upregulated genes and another
list of downregulated genes.
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To create these upregulated and downregulated lists, we sorted the original
general significant only genes list by the log2 value. First, the general list was sorted from
largest to smallest log2 value which provides us with the upregulated genes. All genes
with a log2 value greater than zero were upregulated. Next, we sorted the list from
smallest to largest log2 value providing us with the downregulated genes. All genes with
a log2 value less than zero are downregulated. The top 100 upregulated and
downregulated genes were used to create the new lists of upregulated and downregulated
genes.
Significant Genes Investigation
When genes that were significantly different between NPC and WT mice were
discovered, we wanted to know the importance and function of these significantly
upregulated and downregulated genes. To this end, we used the gene ontology website
“geneontology.org”. First, we looked at the top 100 upregulated genes and then the top
100 downregulated genes. The gene ontology site was useful in determining which genes
are involved in what processes, such as immune response and regulatory pathways. The
top 20 upregulated and downregulated genes were used to show trends.
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Chapter 3
Dendritic Tree Developmental Analysis throughout Postnatal and Early
Development

Since the loss of PCs is the most well documented histological change
documented in mouse models of Niemann-Pick type C disease, to be able to determine
the changes in their dendritic tree length and branching throughout postnatal and early
development, we performed Golgi-Cox staining on the PCs (Figure 8a). The Golgi-Cox
staining procedure allowed for the PCs to be imaged and analyzed using the ImageJ
software. Measurements were taken at ages P14 and P30 which were selected because of
being critical points throughout the development of the PCs dendritic tree (Figure 6a-d).
Changes in the Length of WT and NPC Dendritic Trees between P14 and P30
ImageJ analysis of the total length of PC dendrites at earlier stages in
development, P14, showed that Niemann Pick Type C mouse models had a significantly
longer dendritic tree when compared to WT mouse models at this stage. Although the
NPC mouse model dendrites continue to show growth after P14, later in development at
P30 the dendritic tree of the WT mice is significantly longer when compared to the
Npc1nmf164dendritic tree at this stage (Figure 8).
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Figure 8
Changes in Purkinje Cell
ell Dendritic Tree Total Length Between Npc1nmf164 and WT Mice

A.
Note. (A) Visual differences between P14 WT and NPC dendritic trees after Golgi-Cox
Golgi
staining. (B) The total length (µm) of the Purkinje cell dendrites of Npc1nmf164 mice
(green) was compared to that of the WT mice (gray) at P14 and P30 to determine changes
caused by NPC1. *P<0.005, *** P<0.0005
26

Figure 9
Changes in Dendritic Tree
ree Size and Branching Between Npc1nmf164 and WT Mice

Note. Sholl Analysis was performed to compare the changes between overall tree size and
branching within the Purkinje cell dendritic trees of WT and Npcnmf164mouse models at
(A) P14 and (B) P30.

Changes in the Branching of WT and NPC Dendritic Treess between P14 and P30
We performed Sholl Analysis to determine the size of the Npcnmf164and WT
dendritic trees. This analysis quantifies which circles the dendrites are intersecting. Each
of these circles is represented by a radius measurement to help determine the size of the
dendritic trees. The number of intersections within each of these circles is measured to
quantify the branching of the tree as well. Based on this analysis we found that the
Npcnmf164mice dendritic trees had more branching and larger dendritic trees on average
than the WT mice at P14. At P14 the Npcnmf164trees and the WT trees had similar
branching from a radius of 0µm to around 75µm, at which point the Npcnmf164tree
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continues to grow and have more branching while the WT branching decreases and the
tree only grows to 150µm on average (Figure 9a).
We repeated the branching analysis at P30 and found different results when
compared to the trend to the P14 length analysis. The WT mouse dendritic tree is larger,
growing up to around 240µm, and has more branching than the Npcnmf164dendritic tree.
Unlike at P14, the Npcnmf164dendritic tree shows less branching than the WT tree from
0µm to around 75µm and begins to decrease and stops growing at around 170µm (Figure
9b).
Conclusion
The dendritic trees of the WT and Npcnmf164 mice experience growth changes
throughout postnatal and early development. The changes in the dendritic tree of the
Npcnmf164mice from P14 to P30 show that the average size of the dendritic tree is smaller
at P30 than it was at P14. This suggests that there is something that is starting to cause a
loss in size or degeneration of the Npcnmf164Purkinje cell dendrites between P14 and P30.
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Chapter 4
Next Generation Sequencing of Mus Musculus Cerebellar RNA Samples
Our data have indicated that PCs dendritic tree development is altered at P14 by
the deficiency of NPC1. We also know that at this postnatal stage the phagocytic activity
of NPC1 deficient microglia is increased at the ML where the PC dendrites reside (Boyle
et al., 2020). To further understand which molecular pathways could be leading to these
early pathological changes in NPC1 mice, an RNAseq analysis of P15 cerebella from WT
and NPC1 mice was performed. In this chapter, a detailed description of the analysis and
results are provided.
Quality and Alignment of Next Generation Sequencing RNA Samples
FastQC is a program that allows for performing quality control checks on raw
sequencing data such as our RNAseq data received from Genewiz. FastQC provides an
overview of each sample and breaks the analysis down into several categories to show
where the samples might be having problems in terms of purity and integrity. Prior to
analyzing the NGS samples received back from Genewiz, the sample quality was
evaluated to ensure that the data would be reliable and accurate. The quality of the
samples is critical to have the confidence that the results accurately represent the group of
mice used in this study.
It is also important to evaluate the alignment of the reads with a reference
genome. A reference genome serves as a baseline for comparing experimental RNA
sequences to a known RNA sequence to determine whether any differences or changes
exist between the experimental and reference samples. The reference genome includes
known specific locations of genes or reads within the genome that can give insight into

29

several concepts involving genetics such as gene identity and expression levels. An
overall sequence alignment rate is the percentage of the reads within the experimental
sequence that mapped or aligned with the reference genome.
Sequence alignment is a method in which sequences of proteins, DNA or RNA
are arranged to identify similar sequences or regions. These similar or conserved regions
may be the outcome of structural, evolutionary, or functional relationships between the
aligned sequences. It is these relationships that can help us gain more insight into the
effects of Niemann-pick type C. These regions can be further analyzed, after a successful
alignment, to see gene and transcript expression.
Statistical Analysis of RNAseq Samples through FASTQC
Each RNAseq sample was evaluated for overall sample quality. Each sample's
results provided the basic statistics of the sample (Table 2). The "R1" and "R2" of each
sample were evaluated for quality to ensure that all samples sent to and received back
from Genewiz could be used for analysis. All samples had a sequence length of 150 base
pairs and a %GC between 49 and 51%. Of all the samples, P8-3-15d5-WT is the only
sample with a different %GC between "R1" and "R2" with "R1" having 50% GC and
"R2" having 51% GC (Table 2). The basic statistical analysis also revealed that none of
the samples had sequences flagged as poor quality, meaning that all samples were of
good or passing quality (Table 2). This was confirmed when looking at the graphical
representation of the data for each sample.
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Table 2
Basic Statistics of NGS Data

Note. Basic statistics results of the raw NPC and WT next generation sequencing data
showing quick overview details of each sample sent back from Genewiz (sequence length
is measured in bp).

Categorized Quality Analysis
Each RNAseq sample was evaluated for 10 other modules aside from the “Basic
Statistics” module. These additional modules help to show the quality of different aspects
of each sample, displayed in Table 3. Of all these modules, three of them (per
(
base
sequence
nce quality, per tile sequence quality, and per sequence quality scores)
scores were the
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most reliable/efficient in assessing the overall quality of the samples and were selected as
reference to accept or reject the quality of our samples. After evaluating each sample, we
found that the per base sequence quality, per tile sequence quality, and per sequence
quality scores of each sample were of good or passing quality and were accepted for
further analysis without the need for sequence trimming. All sequences were kept at a
length of 150bp for alignment to the GRCm38 reference genome. All graphical
interpretations of the quality assessment categories for each sample can be seen in
supplemental figure A 1.
Table 3
Quality Control Tested
ested Modules Showing Quality Check Results

Note. The table shows the results for all the modules from the FastQC output. Green
indicates a good or passing, Yellow indicates okay or warning, and Red indicates bad or
failing. The Yellow and Red coloring indicates that a module can and/or should be
looked at more closely if needed.

Overall Sequence Alignment
After running Bowtie sequence alignment, the overall alignmen
alignment rate was
calculated for each of the eight paired
paired-end samples (Table 4).All the samples aligned with
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an overall alignment rate to the reference genome between 74% and 67%. The WT and
NPC1 results show no evidence of a visible pattern in the overall alignment rates. Further
alignment results indicating whether the paired reads are aligned concordantly or
discordantly and how many times they are aligned can be seen in Figure A2.

Table 4
Overall Alignment of RNAseq Samples
Paired Sample ID

Reads

Overall
Alignment Rate

15d1-WT

57565596

70.74%

15d2-NPC

51232518

68.24%

15d2-WT

59052269

73.51%

15d7-NPC

52996438

67.54%

P8-3-15d1-WT

46891113

69.19%

P8-3-15d4-NPC

58599493

70.19%

P8-3-15d5-WT

53480576

69.05%

P8-3-15d6-NPC

51523655

72.86%

Note. The overall alignment rate shows that percentage of reads from our experimental
samples that aligned or mapped with the reference genome GRCm38.
All samples were successfully aligned making them usable for Cuffdiff analysis.
This analysis was used for the measurement of gene expression in each sample. This gene
expression was measured using the FPKM values of each aligned sequence. The
successful alignment of all the WT and NPC1 sample sequences means that the
sequences were all arranged in a readable order. This allowed us to examine the
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expression levels of individual genes to compare and contrast their NPC1 and WT gene
expression. This analysis illustrates how the expression levels are affected in an NPC1
mutant mouse.
Differences in Gene Expression between WT and Npc1nmf164 Mouse Models
Differences in gene expression can provide great insight into how protein
signaling pathways are changed or relevant in an individual impacted by Niemann-pick
type C disease. Understanding gene expression means analyzing which types of proteins
and how many are expressed in a single cell at any given moment in time. The proteins
present in each cell ultimately influence an organism as a whole. Alterations to the
expression of these proteins can result in changes and activation of signaling pathways
where those proteins function. Changes in the expression and activation of proteins
involved in certain signaling cascades can result in diseases such as Niemann-Pick Type
C. We analyzed the gene expression of both WT and NPC1 mice to determine the effect
of NPC at the protein level.
Analyzing the distinct gene expression profile between WT and NPC1 mice
allows us to see which biological functions or pathways may be affected in the NPC1
mouse models. Knowing which functions or pathways may be affected can help us to
understand how the disruptions of the NPC1 and NPC2 protein functions (disruptions
which cause Niemann-pick type C) lead to NPC neurodegeneration and dementia. Once
the top 100 significantly upregulated genes and the top 100 significantly downregulated
genes were identified, we obtained the gene ontology of each of these genes to determine
the role that these genes have within an individual affected with Niemann-Pick type C.

34

Genes of Significantly Different Expression Levels
Upon discovery of differences in the average FPKM levels, which estimate gene
expression, of WT and NPC1 mouse models, we performed a t-test on the FPKM values
of all the genes whose RNA expression was reported by the RNAseq analysis. With a pvalue of 0.05 as a threshold for significant differences, we were able to conclude that
1362 genes found in the RNA samples were of significant difference between the NPC1
and WT mice. Of these 1362 genes, we scaled down the findings to focus on only the top
100 downregulated and upregulated genes. The top 100 significantly upregulated genes
had p-values ranging from 0.00018 to 0.494. Of these, the top 20 downregulated genes
were selected with log2 values ranging from -10.55 to -2.99 (Figure 10). Although the top
20 downregulated genes all have p-values lower than the 0.05 significance threshold, two
of the genes show overlapping 95% confidence level error bars which indicates that they
may not be significantly different from one another.
The top 100 significantly upregulated genes had p-values ranging from 0.00046 to
0.0494. Of these the top 20 upregulated genes were selected with log 2values ranging from
4.07 to 2.50 (Figure 11). Like the downregulated genes, the upregulated genes also all
have p-values less than 0.05. Despite this qualification of significance, six genes show
overlapping 95% confidence level error bars.
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Figure 10
Downregulated Genes are Present in NPC Afflicted Mice

Note. The top 20 significantly downregulated genes that are present in NPC mouse
models. The displayed genes were selected based on the log 2 value with the top 20 shown
above having the smallest log2 values making them the most downregulated genes. Error
bars are created with a 95% confidence level (p=0.05).
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Figure 11
Upregulated Genes are Present in NPC Afflicted Mice

Note. The top 20 significantly upregulated genes that are present in NPC mouse models.
The displayed genes were selected based on the log2 value with the top 20 shown above
having the largest log2 values making them the most upregulated genes. Error bars are
created with a 95% confidence level (p = 0.05).

Conclusion
The overall quality of the RNAseq sample data was accepted as of good and
reliable quality with no indication of a need to trim any of the samples to be less than the
original 150 base pairs. The experimental sequence that did not map with the reference
r
genome could be divergent or changed from the reference sequence. The
he overall
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alignment rate of each of the cerebellar RNA samples was acceptable and like the quality
results, did not suggest any reason for the samples to be rejected from the study. Cuffdiff
analysis revealed a sizable amount of up regulated and down regulated genes within the
NPC mouse model when compared to the gene expression levels of the WT mouse
models. Samples whose SE bars overlap show the gene expression turned off in the
majority (up to three) of the samples out of four samples.
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Chapter 5
Gene Ontology and Biological Functions Affected in Niemann-Pick Type C
Defended Concepts of Biological Function
A biological function can be defined on two different broad levels, “causal role
function” and “selected effect function”. Robert Cummins was the first to propose the
causal role function which emphasizes describing a function in the terms of “how a part
contributes to some overall capacity of the system that contains the part” (Cummins
1975, Thomas 2016). The causal role function concept states that there is no way to
systematically identify what part contributes to the larger system. Cummins theory
focuses on functional analysis rather than taking evolutionary history, or current
evolutionary goals or benefits into account. When looking at the functional analysis, the
goal is to appeal to the capacities of a system’s component parts to explain the capacity of
the system as a whole. Cummins believed that the capacities are not necessarily the goals
or purposes of a system. This concept allows researchers to pick and choose which
capacities of a system they feel are appropriate for functional analysis. They then propose
a way in which these capacities emerge from interactions between component parts
(Amundson & Lauder 1994).
The concept of selected effect function was first proposed by Larry Wright and is
based on the “etiological” definition of function (Wright 1973). This concept is centered
on the belief that the structure or system exists because of the function. Unlike the causal
role function concept of biological functions, the selected effect function concept
integrates evolutionary considerations and dictates that natural selection is the reason
behind the origination of a function. Consequently, this concept allows us to distinguish
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between an accidental effect (e.g., producing sounds or vibrations) and a proper function
(e.g., a heart pumping blood) in contrast to the causal role function concept (Thomas
2016). Although both concepts are dependent on opposite qualifications of functions,
both have been defended by biologists as they apply to a variety of sub disciplines. The
overall distinguishing difference between the two concepts is that one emphasizes “the
activity having the role of a function, rather than the entity itself having a function”
(Thomas 2016).
The lists of the top 100 upregulated and downregulated genes provided us with a
focal point of investigation. Determining the significantly different genes and composing
a list of these genes allows for further research into what function these genes serve.
Knowing the function of the genes that are significantly affected in Niemann-pick type C
mouse models allows researchers and other scientists to begin to have a more in depth
understanding into how the brain is affected by this disease. It also provides researchers
with potential genes, pathways or drug targets for future or developing treatments for
NPC. We can also use this information to determine if the function of these proteins is
supported by the selected effect function or causal role theories.
Gene Ontology of the Top 100 Upregulated and Downregulated Genes
Gene ontology is a representation of the world’s knowledge of the biological
discipline. The gene ontology of the biological domain consists of three aspects:
Molecular function, cellular components, and biological processes. The first aspect,
molecular function, describes how a gene or gene product is involved in biochemical
activity. Such an activity includes binding to ligands and other chemical structures.
Molecular function does not describe the location at which the function occurs but only
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what occurs. Molecular functional terms include “ligands”, “transporters” and “enzymes”
(Ashburner et al. 2011).
The location within a cell where a gene product is active is known as the cellular
component. This aspect relates to the eukaryotic cell structure as opposed to prokaryotic
cell structures. Results from this aspect tell the location within the cell that the gene is
involved in including but not limited to the ‘mitochondria’, ‘endoplasmic reticulum’, and
“nuclear membrane”. This aspect gives insight into what features of the cell may be
affected when gene expression levels are altered (Ashburner et al. 2011)
The third and final aspect is biological processes. A biological process is the goal
to which a gene or product of a gene contributes to. Processes typically involve more than
one molecular function working together in a specified order. During a typical process it
is expected that there is an exchange of resources going into and coming out of the
process (Ashburner et al. 2011). Each aspect of gene ontology can be independently
isolated and do not have to relate back to another. This provides us with more in-depth
detail about how a gene or gene product comes into play within the organism.
Our study focuses on the biological processes that the genes differentially
expressed in our animal models are involved in. The biological processes aspect is the
larger processes also known as biological programs that are achieved by molecular
biology activities. Types of these biological processes include but are not limited to DNA
replication, signal transduction, virus response and regulation of system processes. It is
worth noting that the biological processes evaluated by gene ontology are not equivalent
to any full biological pathways but rather tells which genes are related to or involved in
certain pathways.
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Figure 12
Gene Ontology Results of Top 100 Upregulated Genes

Note. (A) The gene ontology results of the top 100 upregulated genes showing the
significant biological processes that the genes are involved in. The “#” column (to the left
of the “expected” column) designates how many genes from our upregulated list were
involved
ved in the designated process. (B) Example of the breakdown of which upregulated
genes are involved in the resulting processes (defense response to virus results shown).

Significant Biological Processes of Upregulated Genes in the NPC1 Mouse Models
Model
Upon analysis of the top 100 upregulated genes found in the NPC1 mouse model,
three significant (P < 0.05) biological processes were identified. These three processes
are defense response to virus, cytokine
cytokine-mediated
mediated signaling pathway, regulation of
immune response.
nse. These processes were broken down into more specific categories of
processes. The defense response to virus is categorized to include response to virus and
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defense response to symbiont while the regulation of immune response is broken down to
include regulation
egulation of immune system process as well (Figure 12).

Table 5
Genes Involved in Significant B
Biological Processes of Upregulated Genes
enes

Note. Three biological processes were discovered to be significant upon gene ontology
analysis. In Table 5, each main biological process category is color coded (all processes
involved in defense response to virus are colored red, Cytokine
Cytokine-mediated
mediated signaling
pathway
hway colored in yellow, and processes involved in regulation of immune response are
colored green). The significantly upregulated genes involved in each process are
indicated with a check mark.
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Several of these upregulated genes are involved in multiple significant biological
processes including Cxcl10, Zbp1 (both have 5 out of 6 processes listed in Table 5),
Ifitm6 and Oasl2 (both have 4 out of 6 processes listed in Table 5). Due to their
involvement in multiple significant processes, these genes were considered a higher
priority for investigation.
Significant Biological Processes of Downregulated Genes in the NPC1 Mouse Models
Although the gene ontology report of the top 100 upregulated provided us with
significant biological process results, it is unfortunate that the top 100 downregulated
genes show no significant biological processes. There are biological processes that are
reported with a p< 0.05 but the focus of this study was to investigate the significant
differences between NPC1 and WT mice in order to discover potentially helpful
information when it comes to understanding and treating Niemann-pick type C disease.
Conclusion
Upregulated genes discovered in the NPC mouse model are involved in
significant biological processes that all relate to immune or inflammatory response.
CXCL10, Zbp1, Ifitm6 and Oasl2 are significantly upregulated genes that are involved in
more than half of the significant biological processes found during the gene ontology
analysis of NPC mouse model upregulated genes. These genes could have the potential to
be future targets for treatment of NPC and their function could give insight into how the
upregulation of one of these genes impacts the NPC afflicted organism.
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Chapter 6
Discussion and Future Investigations

The role of inflammation is highly emphasized in the literature about
neurodegenerative disorders (Koper et al. 2018). It has been shown that disease
progression is stimulated by proinflammatory responses. Due to the link between
Niemann-pick type C and other neurodegenerative diseases with inflammation, antiinflammatory drugs have been used on animal models created for this condition. The
effect of these drugs being beneficial to anti-inflammation became the target process in
organisms that are afflicted with this disease (Platt et al. 2016).Currently, the cause of
neuroinflammation of the brain is not quite understood by the scientific community,
despite this symptom being present not only in NPC, but also other lysosomal storage
diseases, regardless of the storage material involved (Platt et al 2016). Inflammation fails
to correct in most chronic conditions, possibly due to the inflammatory stimulus being
present in the organism because of the lysosomal storage impairment. The importance of
the significant biological processes discovered during our gene expression analysis is that
inflammatory activity is already occurring during the postnatal development of PCs and it
could become clear how these inflammatory responses affect PCs after pursuing further
investigation into the genes listed in Table 5. CXCL10 and Zbp1 are genes that are both
found in five out of the six of our significant biological processes discovered in the NPC1
mouse model (Table 5). While the Ifitm6 and Oasl2 genes are present in four out of 6 of
these significant biological processes (Table 5).
CXCL10 is a chemokine, a small protein that consists of 70 to 90 amino acids.
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CXCL10 lacks ELR (Glu-Leu-Arg) and is located on chromosome 4q21.21. The
expression of CXCL10 correlates with the tissue infiltration of T cells and it is involved
in the Th1 response (Koper et al. 2018). Both the infiltration of T cells and Th1 response
are associated with an immune response. Th1 response helps to produce proinflammatory
responses that are responsible for killing parasites colonizing the body. The upregulated
expression of this gene could potentially cause excessive proinflammatory responses
which could lead to uncontrolled tissue damage (Berger 2000). CXCL10 has also been
discovered to be over expressed in Alzheimer’s disease.
One of the most important findings about the signaling of CXCL10 is that it is
crucial in the recruitment of microglia and essential in the reorganization of neurons
(Koper et al 2018). Chemokines promote cell migration of nonimmune cells when
inflammation is not present thus assisting with tissue homeostasis. CXCL10 along with
other chemokines have been known to induce chemotaxis and directed cell movement in
cell types which include microglia cells (Clarner et al. 2015). Our results suggest that the
upregulation of CXCL10 in the NPC1 mouse model supports our earlier findings of
microglia movement and the increase in microglia density at 8 and 12 weeks in NPC1
mice.
Zbp1 is a gene whose function is to mediate interferon-induced necroptosis. Other
programmed or regulated processes of cell death (apoptosis and pyroptosis) are also
promoted by Zbp1 (Banoth et al. 2021). Of these, necroptosis has been evaluated as a
mechanism of the loss of neurons. The process of necroptosis is signaled by necrosome
(multiprotein containing RIP1 and RIP3 kinases) formation (Cougnoux et al 2016).
Previous studies have found that necroptosis may very well be the leading cause of
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neuronal loss in NPC1 over apoptosis (Patel et al. 1999, German et al. 2001). It has been
found that necroptosis may be a factor in neuronal death in other neurodegenerative
diseases such as Huntington’s disease and Gaucher’s disease (Vitner et al. 2014).
The importance of Zbp1 being identified in our data as a gene involved in
processes involving virus response and immune response is that necroptosis has been
seen as the cell death mechanism in the neurodegenerative disorders that involve
neuroinflammation (German et al. 2001, Zhu et al. 2011, Re et al 2014). NPC1 is one of
the neurodegenerative diseases associated with neuroinflammation, an aspect possibly
responsible for NPC1 disease progression (Cologna 2014, Williams 2014, Peake 2007).
Analysis of NPC1 brain tissue by Liu and his team suggested that the neuronal
death present in the brain tissue was caused by necroptosis (Liu 2009). Also, our
laboratory has demonstrated that microglia, important players of neuroinflammation,
have early interactions and phagocytic activity that coincide with the degeneration of PC
dendrites (Kavetsky 2019, Boyle 2001).
With the previous scientific findings on the link between necroptosis and the
cellular death in individuals with NPC1, the increased expression of Zbp1 in our mouse
models suggests that this may have contributed to their NPC disease progression. Zbp1’s
involvement in cellular death could mean that the increase in Zbp1 gene expression might
be linked to the death and degeneration of PCs that we discovered in our previously
conducted studies.
IFITM6 protein is part of a family of proteins known as interferon-inducible
transmembrane proteins (IFITMs). These proteins are small transmembrane proteins that
belong to the interferon-stimulated gene (ISG) superfamily. The Ifitm6 gene that we
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discovered, and which has significantly upregulated expression, is located on
chromosome 7 in mice (Lu et al. 2017). The IFITM gene family has many functions
which include osteoblast function and bone mineralization and specification of germ
cells. Ifitm6 along with Ifitm1-3 both play a role in immune functions and are virusrestriction factors (Yanez et al. 2020). This is consistent with our results displayed in
Table 5. There is not much information on the exact functions of Ifitm6, but other studies
reported that the proteins of the IFITM family may help to promote the transportation of
viral particles into lysosomes thereby limiting viral infection (Liao et al. 2019).
Oasl2 is a gene in a family of ISGs known as Oligoadenylate synthetases (OAS).
OAS degrades viral and host RNA and RNase L thus inhibiting viral replication during
the early stages of viral infection (Choi et al. 2015). This group of ISGs can synthesize
2’-5’ oligoadenylates which are oligomers of adenosine from ATP (Rebouillat et al
1998). Synthesizing these oligoadenylates activates RNase L by inducing RNA
degradation (Zhu et al. 2014) and is indicated in the antiviral action of interferon
mechanism. They are also implicated in cell differentiation, cell growth, and apoptosis
(Rebouillat et al 1998). Viral infection has been found to rapidly induce OASL by way of
interferon regulatory factor 3 (IRF3) and interferon signaling (Jianzhong et al. 2014). The
Oasl2 gene found in our mouse model has been determined to be functionally similar to
that of the human OASL which also functions in antiviral signaling.
Future Research Directions
Based on our results from the gene ontology and gene expression analysis there
are several different aspects that could be investigated in our future research. The first
direction is the investigation of the CXCL10 role in NPC disease. With CXCL10
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influencing microglia recruitment, further research could consist of analyzing the
abundance of CXCL10 gene expression in the mouse model cerebellum at different age
stages including P10, P30, P60 and P90. This would be to determine if there is a
correlation between microglia movement and density in the layers of the cerebellum and
CXCL10 gene expression. Since CXCL10 promotes cell migration like other
chemokines, we would expect to find that if there is an increase in CXCL10 gene
expression then there would be more migration of microglia throughout the cerebellum.
Similar exploration would focus on the Zbp1 gene. Since Zbp1 is involved in
promoting regulated and programmed processes of cellular death in neurodegenerative
diseases, the scope of the future investigation would be to determine if there is a possible
correlation between the level of gene expression of Zbp1 and the degradation and death
of PCs(discovered in our previous studies). To this end we would want to test the Zbp1
gene expression levels over time at different age points such as 4, 8, and 12 weeks, to
determine if there is an increase in gene expression. If an increase is noted, then we could
compare the amount of degradation of PCs at each time point and determine if the two
correlate directly or reciprocally.
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Appendix
Supplemental Figures
Figure A1
FastQC Graphical Analysis
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Note. The results of the quality control checks from FastQC software showing good
quality reads analysis of all 16 RNAseq samples provided to the software. The figure
shows the graphical results for the following 10 modules from the FastQC output: per
base sequence quality, per tile sequence quality, per sequence quality scores, per base
sequence content, per sequence GC content, per base N content, sequence length
distribution, sequence duplication levels, overrepresented sequences, and adapter
content. This figure shows the graphical representation of Table 3 which shows the
quality of each of the 10 modules shown above.
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Figure A2
Alignment breakdown of RNAseq WT and NPC samples
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Note. The alignment of each sample was broken down into several categories. Paired
reads were broken down into aligning concordantly 0, 1, or greater than 1 time. The
paired reads that aligned concordantly 0 times were broken down into how many
aligned discordantly.
tly. The paired reads that aligned 0 times concordantly and
discordantly were then broken down into mates that made pairs and how those mate
pairs were aligning (0, 1, or greater than 1 times).
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